Merck (MRK) terminates a mid-stage trial for an oral Alzheimer's therapy due to concerns over liver toxicity.
https://seekingalpha.com/news/4024108-merck-ends-trial-alzheimers-drug-liver-toxicity
Merck (MRK) terminates a mid-stage trial for an oral Alzheimer's therapy due to concerns over liver toxicity.
https://seekingalpha.com/news/4024108-merck-ends-trial-alzheimers-drug-liver-toxicity
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.